carbamazepine epoxide has been researched along with Intellectual Disability in 1 studies
carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The bioavailability of CBZ from the two preparations was similar." | 6.67 | Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Kaski, M; Sivenius, J; Tuominen, J, 1991) |
| " The bioavailability of CBZ from the two preparations was similar." | 2.67 | Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Kaski, M; Sivenius, J; Tuominen, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaski, M | 1 |
| Heinonen, E | 1 |
| Sivenius, J | 1 |
| Tuominen, J | 1 |
| Anttila, M | 1 |
1 trial available for carbamazepine epoxide and Intellectual Disability
| Article | Year |
|---|---|
Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
Topics: Adolescent; Adult; Carbamazepine; Child; Delayed-Action Preparations; Double-Blind Method; Drug Admi | 1991 |